Gland Pharma Fundamentals
P/E Ratio
35.45
P/B Ratio
3.06
Div. Yield
0.99
Sector P/E
62.53
Sector P/B
2.77
Sec. Div. Yield
0.57
Gland Pharma Fundamentals is currently trading with a P/E Ratio of 35.45, compared to the sector average of 62.53. Its P/B Ratio stands at 3.06, while the sector’s is 2.77. In terms of returns, the stock offers a Dividend Yield of 0.99%, which is than the sector’s 0.57%.
Gland Pharma Score Card
Price
Attractive
Growth
Moderate
Quality
Good
Management
Good
On its scorecard, Gland Pharma reflects: Price – Attractive, Growth – Moderate, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
